{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "cfres_id": "41544",
      "product_res_number": "Z-0061-06",
      "event_date_initiated": "2005-08-29",
      "event_date_posted": "2005-10-15",
      "recall_status": "Terminated",
      "event_date_terminated": "2008-02-06",
      "res_event_number": "33250",
      "product_code": "LNX",
      "product_description": "Baxter''s Patient Care System (BPCS) software, Pharmacy Management - Inpatient - product code 2M5013 and Point of Care - product code 2M5014; Baxter Healthcare Corporation, 1 Baxter Parkway, Deerfield, IL 60015, USA, made in Canada",
      "code_info": "all units of software versions 4.0 (66) and 4.1 (77)",
      "firm_fei_number": "1416980",
      "recalling_firm": "Baxter Healthcare Corp.",
      "address_1": "Rt. 120 & Wilson Rd",
      "city": "Round Lake",
      "state": "IL",
      "postal_code": "60073",
      "additional_info_contact": "Center for One Baxter \n800-422-9837",
      "reason_for_recall": "If an administrative user modifies any of the seven pre-defined Monitoring Parameters when they are attached to a medication in the drug file, a Point of Care end user will be unable to enter monitoring parameter  results on the handheld.",
      "root_cause_description": "Other",
      "action": "Urgent Device Correction recall letters dated 8/29/05 were sent to the direct accounts on the same date via first class mail. The letter describes the issue with the modification or creation of a Monitoring Parameter, and informed the accounts that modifying the Monitoring Parameters could result in a potential for a patient receiving an incorrect medication or an incorrect medication dosage.  The accounts were advised that administrative end users should never modify the seven pre-defined Monitoring Parameters or create new Monitoring Parameters.",
      "product_quantity": "5 units",
      "distribution_pattern": "Missouri, Massachusetts, Vermont, California and Canada.",
      "openfda": {
        "k_number": [
          "K921846"
        ]
      }
    }
  ]
}